John J.  Kirby net worth and biography

John Kirby Biography and Net Worth

John Kirby joined the company in 2015 and was appointed Chief Financial Officer in July 2019. Before joining Idera, Mr. Kirby served as Assistant Controller at Endo Pharmaceuticals. Prior to joining Endo, Mr. Kirby served as Vice President, Chief Accounting Officer and Corporate Controller at ViroPharma Incorporated. Mr. Kirby began his career at KPMG, LLP and served as a Regional Audit Director at AstraZeneca Pharmaceuticals prior to joining ViroPharma. Mr. Kirby received his Bachelor of Science from Villanova University and is a licensed certified public accountant.

What is John J. Kirby's net worth?

The estimated net worth of John J. Kirby is at least $0.00 as of March 25th, 2021. Mr. Kirby owns 27,632 shares of Idera Pharmaceuticals stock worth more than $0 as of April 23rd. This net worth evaluation does not reflect any other assets that Mr. Kirby may own. Additionally, Mr. Kirby receives an annual salary of $477,410.00 as CFO at Idera Pharmaceuticals. Learn More about John J. Kirby's net worth.

How old is John J. Kirby?

Mr. Kirby is currently 50 years old. There are 8 older executives and no younger executives at Idera Pharmaceuticals. The oldest executive at Idera Pharmaceuticals is Mr. Andy Jordan, Chief Strategy Officer, who is 75 years old. Learn More on John J. Kirby's age.

What is John J. Kirby's salary?

As the CFO of Idera Pharmaceuticals, Inc., Mr. Kirby earns $477,410.00 per year. The highest earning executive at Idera Pharmaceuticals is Mr. Bryant David Lim, Chief Bus. Officer & Gen. Counsel, who commands a salary of $480,960.00 per year. Learn More on John J. Kirby's salary.

How do I contact John J. Kirby?

The corporate mailing address for Mr. Kirby and other Idera Pharmaceuticals executives is 505 EAGLEVIEW BLVD. SUITE 212, EXTON PA, 19341. Idera Pharmaceuticals can also be reached via phone at (484) 348-1600 and via email at [email protected]. Learn More on John J. Kirby's contact information.

Has John J. Kirby been buying or selling shares of Idera Pharmaceuticals?

John J. Kirby has not been actively trading shares of Idera Pharmaceuticals within the last three months. Most recently, on Friday, December 17th, John J. Kirby bought 10,000 shares of Idera Pharmaceuticals stock. The stock was acquired at an average cost of $0.61 per share, with a total value of $6,100.00. Learn More on John J. Kirby's trading history.

Who are Idera Pharmaceuticals' active insiders?

Idera Pharmaceuticals' insider roster includes John Kirby (CFO), Bryant Lim (SVP), Daniel Soland (COO), and Elizabeth Tarka (Insider). Learn More on Idera Pharmaceuticals' active insiders.

John J. Kirby Insider Trading History at Idera Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/17/2021Buy10,000$0.61$6,100.00View SEC Filing Icon  
3/25/2021Sell6,250$1.42$8,875.0027,632View SEC Filing Icon  
1/12/2021Sell1,693$4.22$7,144.46View SEC Filing Icon  
1/5/2021Sell862$3.90$3,361.80View SEC Filing Icon  
1/7/2020Sell911$1.78$1,621.58View SEC Filing Icon  
See Full Table

John J. Kirby Buying and Selling Activity at Idera Pharmaceuticals

This chart shows John J Kirby's buying and selling at Idera Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Idera Pharmaceuticals Company Overview

Idera Pharmaceuticals logo
Aceragen, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $0.50
Low: $0.17
High: $7.23

2 Week Range

Now: N/A

Volume

21,870 shs

Average Volume

464,030 shs

Market Capitalization

$450.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.25